Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07515079 |
| Consolidated Lead Sponsor | Bio-Thera Solutions |
| Therapeutic Condition Cohort | Endocrinology, Obesity, and Metabolic |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 406 participants (ESTIMATED) |
| Registered Start Date | 2024-10-09 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Peking University Third Hospital | Beijing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, China | Open Hospital Dossier -> |
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.